3-(4-((1R,3aS,5aR,5bR,7aR,11aS,13aR,13bR)-3a-(benzyloxycarbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)phenyl)propanoic acid → (1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-9-[4-(2-carboxyethyl)phenyl]-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysene-3a-carboxylic acid
반응식
C([O:8][C:9]([C@:11]12[CH2:47][CH2:46][C@@H:45]([C:48]([CH3:50])=[CH2:49])[C@@H:12]1[C@@H:13]1[C@@:26]([CH3:29])([CH2:27][CH2:28]2)[C@@:25]2([CH3:30])[CH:16]([C@:17]3([CH3:44])[C@@H:22]([CH2:23][CH2:24]2)[C:21]([CH3:32])([CH3:31])[C:20]([C:33]2[CH:38]=[CH:37][C:36]([CH2:39][CH2:40][C:41]([OH:43])=[O:42])=[CH:35][CH:34]=2)=[CH:19][CH2:18]3)[CH2:15][CH2:14]1)=[O:10])C1C=CC=CC=1>C(OCC)(=O)C.[Pd]>[C:41]([CH2:40][CH2:39][C:36]1[CH:37]=[CH:38][C:33]([C:20]2[C:21]([CH3:32])([CH3:31])[C@H:22]3[C@:17]([CH3:44])([CH2:18][CH:19]=2)[C@@H:16]2[C@:25]([CH3:30])([C@@:26]4([CH3:29])[C@H:13]([CH2:14][CH2:15]2)[C@H:12]2[C@H:45]([C:48]([CH3:50])=[CH2:49])[CH2:46][CH2:47][C@:11]2([C:9]([OH:10])=[O:8])[CH2:28][CH2:27]4)[CH2:24][CH2:23]3)=[CH:34][CH:35]=1)([OH:43])=[O:42]참가 물질
반응물 1
생성물 1
시약·촉매·용매 2
실험 절차
A mixture of 3-(4-((1R,3aS,5aR,5bR,7aR,11aS,13aR,13bR)-3a-(benzyloxycarbonyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)phenyl)propanoic acid (60 mg, 0.089 mmol) and 10% Pd/C (28.3 mg, 0.027 mmol) in Ethyl acetate (2 mL) was stirred under 1 ATM of H2 for 24 hours. LCMS indicated the completion of the reaction. The reaction mixture was filtered and the white solid was collected. The solid was purified by Prep. HPLC to provide the desired product, (1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-9-(4-(2-carboxyethyl)phenyl)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid, as white solid (10.32 mg, 30%). LCMS: m/e 585.59 (M−H)−, 4.38 min (method 2). 1H NMR (599 MHz, DMSO-D6_CDCl3) δ ppm 0.91 (s, 3H), 0.93 (s, 3H), 1.00 (s, 6H), 1.02 (s, 3H), 1.05-1.72 (m, 17H), 1.71 (s, 3H), 1.84-1.95 (m, 2H), 2.10 (dd, J=17.58, 6.44 Hz, 1H), 2.20 (d, J=11.72 Hz, 1H), 2.30-2.39 (m, 1H), 2.60 (s, 2H), 2.85 (t, J=7.62 Hz, 2H), 3.02 (td, J=10.25, 5.27 Hz, 1H), 4.61 (br. s, 1H), 4.74 (s, 1H), 5.23 (d, J=5.27 Hz, 1H), 6.94 (d, J=7.62 Hz, 1H), 6.98 (s, 1H), 7.12 (d, J=8.20 Hz, 1H), 7.20 (t, J=7.62 Hz, 1H).
후처리
- customthe completion of the reaction
- filtrationThe reaction mixture was filtered
- customthe white solid was collected
- customThe solid was purified by Prep
출처 및 근거
- ORD 기록
- ord-0626634343cf47f1972c3bd5dea7806a
- 출처 데이터셋
- uspto-grants-2014_06
- 특허 번호
- US08754068B2
반응 노트
불러오는 중…